Loss of imprinting of insulin-like growth factor 2 is associated with increased risk of lymph node metastasis and gastric corpus cancer

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Lu, Yang ^a   Lu, Ping ^b   Zhu, Zhi ^b   Xu, Huimian ^b   Zhu, Xike ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b China Medial University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

RNA H19; SOMATOMEDIN B; IGF2 PROTEIN, HUMAN; KCNQ1OT1 PROTEIN, HUMAN; UNTRANSLATED RNA; VOLTAGE GATED POTASSIUM CHANNEL;

ADULT; ARTICLE; CANCER RISK; CHINESE; DEMOGRAPHY; FEMALE; GENE; GENE AMPLIFICATION; GENE EXPRESSION; GENOME IMPRINTING; H19 GENE; HUMAN; HUMAN TISSUE; IGF2 GENE; LIT1 GENE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STOMACH CANCER; AGED; ASIAN; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOSITY LOSS; MIDDLE AGED; PATHOLOGY; RISK FACTOR; STOMACH TUMOR;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOMIC IMPRINTING; HUMANS; INSULIN-LIKE GROWTH FACTOR II; LOSS OF HETEROZYGOSITY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; POTASSIUM CHANNELS, VOLTAGE-GATED; RISK FACTORS; RNA, UNTRANSLATED; STOMACH NEOPLASMS;

EID: 70349841140     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-125     Document Type: Article

References (51)

1. A genetic approach to cancer epigenetics. AP Feinberg, Cold Spring Harb Symp Quant Biol 2005 70 335 341 10.1101/sqb.2005.70.027 16869770
2. Genomic Imprinting and Cancer: From Primordial Germ Cells to Somatic Cells. A Murrell, Scientific World J 2006 6 1888 1910
3. Imprinting and disease. J Walter M Paulsen, Semin Cell Dev Biol 2003 14 101 110 10.1016/S1084-9521(02)00142-8 12524013
4. Epigenetic deregulation of imprinting in congenital diseases of aberrant growth. K Delaval A Wagschal R Feil, BioEssays 2006 28 453 459 10.1002/bies.20407 16615080
5. Physical linkage of two mammalian imprinted genes, H19 and insulin-like growth factor 2. S Zemel MS Bartolomei SM Tilghman, Nat Genet 1992 2 61 65 10.1038/ng0992-61 1303252
6. Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer. D Takai FA Gonzales YC Tsai MJ Thayer PA Jones, Hum Mol Genet 2001 10 2619 2626 10.1093/hmg/10.23.2619 11726548
7. Loss of imprinting of insulinlike growth factor-2 (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor. JD Ravenel KW Broman EJ Perlman EL Niemitz TM Jayawardena DW Bell DA Haber H Uejima AP Feinberg, J Natl Cancer Inst 2001 93 1698 1703 10.1093/jnci/93.22.1698 11717330
8. Loss of imprinting of insulin-like growth factor-2 in Wilms'tumor commonly involves altered methylation but not mutations of CTCF or its binding site. H Cui EL Niemitz JD Ravenel P Onyango SA Brandenburg VV Lobanenkov AP Feinberg, Cancer Res 2001 61 4947 4950 11431321
9. The H19 transcript is associated with polysomes and may regulate IGF2 expression in trans. YM Li G Franklin HM Cui K Svensson XB He G Adam R Ohlsson S Pfeifer, J Biol Chem 1998 273 28247 28252 10.1074/jbc.273.43.28247 9774446
10. Cancer epigenetics takes center stage. AP Feinberg, Proc Natl Acad Sci USA 2001 98 392 394 10.1073/pnas.98.2.392 11209042
11. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumor. MJ Steenman S Rainier CJ Dobry P Grundy IL Horon AP Feinberg, Nat Genet 1994 7 433 439 10.1038/ng0794-433 7920665
12. Imprinting of IGF2 and H19: lack of reciprocity in sporadic Beckwith-Wiedemann syndrome. JA Joyce WK Lam DJ Catchpoole P Jenks W Reik ER Maher PN Schofield, Hum Mol Genet 1997 6 1543 1548 10.1093/hmg/6.9.1543 9285792
13. Igf2 imprinting in development and disease. W Reik M Constancia W Dean K Davies L Bowden A Murrell R Feil J Walter G Kelsey, Int J Dev Biol 2000 44 145 150 10761859
14. Insulin-like growth factor ligands, receptors, and binding proteins in cancer. E Foulstone S Prince O Zaccheo JL Burns J Harper C Jacobs D Church AB Hassan, J Pathol 2005 205 145 153 10.1002/path.1712 15641016
15. Expression of insulin-like growth factor 2 mRNA in human gastric cancer. T Shiraishi M Mori M Yamagata M Haraguchi H Ueo K Sugimachi, Int J Oncol 1998 13 519 523 9683787
16. Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCFbinding site. GA Ulaner TH Vu T Li JF Hu XM Yao Y Yang R Gorlick P Meyers J Healey M Ladanyi AR Hoffman, Hum Mol Genet 2003 12 535 549 10.1093/hmg/ddg034 12588801
17. Frequent loss of imprinting of IGF2 and MEST in lung adenocarcinoma. M Kohda H Hoshiya M Katoh I Tanaka R Masuda T Takemura M Fujiwara M Oshimura, Mol Carcinog 2001 31 184 191 10.1002/mc.1053 11536368
18. Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma. AK el-Naggar S Lai SA Tucker GL Clayman H Goepfert WK Hong V Huff, Oncogene 1999 18 7063 7069 10.1038/sj.onc.1203192 10597307
19. Regional loss of imprinting of the insulin-like growth factor 2 gene occurs in human prostate tissues. DF Jarrard MJ Bussemakers GS Bova WB Isaacs, Clin Cancer Res 1995 1 1471 1478 9815946
20. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. H Cui M Cruz-Correa FM Giardiello DF Hutcheon DR Kafonek S Brandenburg Y Wu X He NR Powe AP Feinberg, Science 2000 299 1753 1755 10.1126/science.1080902
21. Insulin-like growth factor 2 supply modifies growth of intestinal adenoma in Apc(Min/+) mice. AB Hassan JA Howell, Cancer Res 2000 60 1070 1076 10706126
22. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. H Cui IL Horon R Ohlsson SR Hamilton AP Feinberg, Nat Med 1998 4 1276 1280 10.1038/3260 9809551
23. Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insulin-like growth factor 2 imprinting. MP Lee MR DeBaun K Mitsuya HL Galonek S Brandenburg M Oshimura AP Feinberg, Proc Natl Acad Sci USA 1999 96 5203 5208 10.1073/pnas.96.9.5203 10220444
24. LIT1, an imprinted antisense RNA in the human KvLQT1 locus identified by screening for differentially expressed transcripts using monochromosomal hybrids. K Mitsuya M Meguro MP Lee M Katoh TC Schulz H Kugoh MA Yoshida N Niikawa AP Feinberg M Oshimura, Hum Mol Genet 1999 8 1209 1217 10.1093/hmg/8.7.1209 10369866
25. Loss of imprinting of long QT intronic transcript 1 in colorectal cancer. K Tanaka G Shiota M Meguro K Mitsuya M Oshimura H Kawasaki, Oncology 2001 60 268 273 10.1159/000055328 11340379
26. Expression profile of LIT1/KCNQ1OT1 and epigenetic status at the KvDMR1 in colorectal cancers. S Nakano K Murakami M Meguro H Soejima K Higashimoto T Urano H Kugoh T Mukai M Ikeguchi M Oshimura, Cancer Sci 2006 97 1147 1154 10.1111/j.1349-7006.2006.00305.x 16965397
27. Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer. H Soejima T Nakagawachi W Zhao K Higashimoto T Urano S Matsukura Y Kitajima M Takeuchi M Nakayama M Oshimura K Miyazaki K Joh T Mukai, Oncogene 2004 23 4380 4388 10.1038/sj.onc.1207576 15007390
28. Loss of imprinting and overexpression of IGF2 gene in gastric adenocarcinoma. MS Wu HP Wang CC Lin JC Sheu CT Shun WJ Lee JT Lin, Cancer Lett 1997 120 9 14 10.1016/S0304-3835(97)00279-6 9570380
29. Loss of imprinting of insulin growth factor 2 gene: a potential heritable biomarker for colon neoplasia predisposition. M Cruz-Correa H Cui FM Giardiello NR Powe L Hylind A Robinson DF Hutcheon DR Kafonek S Brandenburg Y Wu X He AP Feinberg, Gastroenterology 2004 126 964 970 10.1053/j.gastro.2003.12.051 15057734
30. Epigenetic heterogeneity at imprinted loci in normal populations. Biochem Biophys. T Sakatani M Wei M Katoh C Okita D Wada K Mitsuya M Meguro M Ikeguchi H Ito B Tycko M Oshimura, Res Commun 2001 283 1124 1130
31. CTCF binding at the insulin-like growth factor-2 (IGF2)/H19 imprinting control region is insufficient to regulate IGF2/H19 expression in human tissues. GA Ulaner Y Yang JF Hu T Li TH Vu AR Hoffman, Endocrinology 2003 144 4420 4426 10.1210/en.2003-0681 12960026
32. Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice. T Sakatani A Kaneda CA Iacobuzio-Donahue MG Carter S de Boom Witzel H Okano MS Ko R Ohlsson DL Longo AP Feinberg, Science 2005 307 1976 1978 10.1126/science.1108080 15731405 (Pubitemid 40404709)
33. Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis. P Vogiatzi C Vindigni F Roviello A Renieri A Giordano, J Cell Physiol 2007 211 287 295 10.1002/jcp.20982 17238139
34. The relationship of insulin-like growth factor-2, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer. L Lu D Katsaros A Wiley IA Rigault de la Longrais HA Risch M Puopolo H Yu, Clin Cancer Res 2006 12 1208 1214 10.1158/1078-0432.CCR-05-1801 16489075
35. Loss of imprinting and loss of heterozygosity on 11p15.5 in head and neck squamous cell carcinomas. CA Rainho LP Kowalski SR Rogatto, Head Neck 2001 23 851 859 10.1002/hed.1124 11592232
36. Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. MR DeBaun EL Niemitz DE McNeil SA Brandenburg MP Lee AP Feinberg, Am J Hum Genet 2002 70 604 611 10.1086/338934 11813134
37. Loss of imprinting of insulin-like growth factor 2 is associated with increased risk of proximal colon cancer. JM Liou MS Wu JT Lin HP Wang SP Huang HM Chiu YC Lee YB Lin CT Shun JT Liang, Eur J Cancer 2007 43 1276 1282 10.1016/j.ejca.2007.01.041 17382534
38. Clinicopathological characteristics of colorectal cancers with loss of imprinting of insulin-like growth factor 2. J Sasaki F Konishi YJ Kawamura T Kai O Takata T Tsukamoto, Int J Cancer 2006 119 80 83 10.1002/ijc.21741 16432831
39. An antisense RNA regulates the bidirectional silencing property of the Kcnq1 imprinting control region. N Thakur VK Tiwari H Thomassin RR Pandey M Kanduri A Göndör T Grange R Ohlsson C Kanduri, Mol Cell Biol 2004 24 7855 7862 10.1128/MCB.24.18.7855-7862.2004 15340049
40. Regional loss of imprinting and growth deficiency in mice with a targeted deletion of KvDMR1. GV Fitzpatrick PD Soloway MJ Higgins, Nat Genet 2002 32 426 431 10.1038/ng988 12410230
41. Epigenetic dynamics of the Kcnq1 imprinted domain in the early embryo. A Lewis K Green C Dawson L Redrup KD Huynh JT Lee M Hemberger W Reik, Development 2006 133 4203 4210 10.1242/dev.02612 17021040
42. A developmental window of opportunity for imprinted gene silencing mediated by DNA methylation and the Kcnq1ot1 noncoding RNA. K Green A Lewis C Dawson W Dean B Reinhart JR Chaillet W Reik, Mamm Genome 2007 18 32 42 10.1007/s00335-006-0092-9 17245608
43. Elongation of the Kcnq1ot1 transcript is required for genomic imprinting of the neighboring genes. D Mancini-Dinardo SJ Steele JM Levorse RS Ingram SM Tilghman, Genes Dev 2006 20 1268 1282 10.1101/gad.1416906 16702402
44. The length of the transcript encoded from the Kcnq1ot1 antisense promoter determines the degree of silencing. C Kanduri N Thakur RR Pandey, EMBO J 2006 25 2096 2106 10.1038/sj.emboj.7601090 16628224
45. Clinical implications of metastatic lymph node ratio in gastric cancer. C Liu P Lu Y Lu H Xu S Wang J Chen, BMC Cancer 2007 10 200 10.1186/1471-2407-7- 200
46. Clinicopathological variables associated with lymph node metastasis in submucosal invasive gastric cancer. S Ohashi S Okamura F Urano M Maeda, Gastric Cancer 2007 10 241 250 10.1007/s10120-007-0442-7 18095080
47. Advanced gastric carcinoma with signet ring cell histology. C Li S Kim JF Lai WJ Hyung WH Choi SH Choi SH Noh, Oncology 2007 72 64 68 10.1159/000111096 18004078
48. Distribution of solitary lymph nodes in primary gastric cancer: A retrospective study and clinical implications. CG Liu P Lu Y Lu F Jin HM Xu SB Wang JQ Chen, World J Gastroenterol 2007 13 4776 4780 17729400
49. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma. Y Kolev H Uetake S Iida T Ishikawa T Kawano K Sugihara, Ann Surg Oncol 2007 14 2738 2747 17687613
50. Clinicopathological and biological significance of mitotic centromere-associated kinesin overexpression in human gastric cancer. Y Nakamura F Tanaka N Haraguchi K Mimori T Matsumoto H Inoue K Yanaga M Mori, Br J Cancer 2007 97 543 549 10.1038/sj.bjc.6603905 17653072
51. Tripartite motif-containing 29 (TRIM29) is a novel marker for lymph node metastasis in gastric cancer. Y Kosaka H Inoue T Ohmachi T Yokoe T Matsumoto K Mimori F Tanaka M Watanabe M Mori, Ann Surg Oncol 2007 14 2543 2549 10.1245/s10434-007-9461-1 17597343